Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19006916 | 0.88 | ADORA3 (0.34) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL18987135 | 0.83 | ADORA3 (0.35) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL20615092 | 0.77 | KDM4E (0.33) | MAPTALDH1A1KDM4ERAB9APOLB | |
| SCHEMBL17691581 | 0.76 | TP53 (0.43) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL15248444 | 0.76 | MAPT (0.43) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL16726767 | 0.76 | PTGER4 (0.37) | MAPTALDH1A1TP53MEN1KMT2A | |
| SCHEMBL24810553 | 0.75 | ALDH1A1 (0.43) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL16726761 | 0.74 | ALDH1A1 (0.41) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL16726773 | 0.74 | ALDH1A1 (0.41) | MAPTNPSR1ALDH1A1MAPK1TP53 | |
| SCHEMBL16726770 | 0.74 | ALDH1A1 (0.44) | MAPTNPSR1ALDH1A1MAPK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11214585-B2 | Light-emitting composition | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2022-01-04 | — | — | US | disclosed |
| EP-3390418-B1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECH LTD (GB) | 2020-08-05 | — | — | EP | disclosed |
| US-20190002629-A1 | LIGHT-EMITTING COMPOSITION | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-01-03 | — | — | US | disclosed |
| US-20190002488-A1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-01-03 | — | — | US | disclosed |
| WO-2017103584-A1 | LIGHT-EMITTING COMPOUND | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017103586-A1 | LIGHT-EMITTING COMPOSITION | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11214585-B2 | Light-emitting composition | CRY1, CRY2, ARL1 | MAPT 977/4885NPSR1 3503/4885ALDH1A1 908/4885 |
| US-20190002488-A1 | LIGHT-EMITTING COMPOUND | AR, ARL1, IK | MAPT 2235/4885NPSR1 3164/4885ALDH1A1 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.